MedPath
TGA Approval

APO-MONTELUKAST montelukast 4 mg (as sodium) chewable tablet bottle (179111)

179111

APO-MONTELUKAST montelukast 4 mg (as sodium) chewable tablet bottle

Arrotex Pharmaceuticals Pty Ltd

November 15, 2011

Medicine

Medicine

Active

Registered

Active Ingredients

montelukast sodium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-MONTELUKAST montelukast 4 mg (as sodium) chewable tablet bottle (179111) - TGA 批准文号 | MedPath